Imaging Manifestations of Von Hippel Lindau Disease

Abstract Introduction and importance: Von Hippel-Lindau (VHL) disease is a rare genetic condition inherited in an autosomal dominant manner. It was first described independently by Von Hippel in 1911 and Lindau in 1926. The disease affects approximately 1 in every 36,000 live births. VHL is known for causing both benign and malignant tumors, along with cysts in various organs. Early and accurate diagnosis is crucial for effective prognosis and management. Case presentation: In this study, we present a case of a 48-year-old man diagnosed with VHL disease, characterized by multiple lesions in the central nervous system (CNS), retina, and renal cortex. He underwent surgical treatment and showed significant improvement, with notable alleviation of his signs and symptoms observed at a 3-month follow-up. Discussion: VHL disease involves the development of both benign and malignant tumors, as well as cysts in several organs. It is inherited in an autosomal dominant manner with nearly complete penetrance across generations. Surgical intervention is typically used to manage CNS lesions. Regular follow-up appointments are essential for monitoring the condition. Conclusions : VHL disease is highly complex, requiring diagnosis and genetic testing for both patients and their family members. Close monitoring of carriers of the mutated gene is essential to achieve early diagnosis and effective treatment of malignancies. The significant expenses associated with diagnostic tests and surgical treatments pose a substantial challenge. Therefore, government support and financial assistance are crucial aspects to address in managing this condition.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-11-30
DOI
https://doi.org/10.5281/zenodo.15449102
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Imaging Manifestations of Von Hippel Lindau Disease

Zenodo (CERN European Organization for Nuclear Research)
Cancer, Hypoxia, and Metabolism
article

Imaging Manifestations of Von Hippel Lindau Disease

article en

Abstract

Abstract Introduction and importance: Von Hippel-Lindau (VHL) disease is a rare genetic condition inherited in an autosomal dominant manner. It was first described independently by Von Hippel in 1911 and Lindau in 1926. The disease affects approximately 1 in every 36,000 live births. VHL is known for causing both benign and malignant tumors, along with cysts in various organs. Early and accurate diagnosis is crucial for effective prognosis and management. Case presentation: In this study, we present a case of a 48-year-old man diagnosed with VHL disease, characterized by multiple lesions in the central nervous system (CNS), retina, and renal cortex. He underwent surgical treatment and showed significant improvement, with notable alleviation of his signs and symptoms observed at a 3-month follow-up. Discussion: VHL disease involves the development of both benign and malignant tumors, as well as cysts in several organs. It is inherited in an autosomal dominant manner with nearly complete penetrance across generations. Surgical intervention is typically used to manage CNS lesions. Regular follow-up appointments are essential for monitoring the condition. Conclusions : VHL disease is highly complex, requiring diagnosis and genetic testing for both patients and their family members. Close monitoring of carriers of the mutated gene is essential to achieve early diagnosis and effective treatment of malignancies. The significant expenses associated with diagnostic tests and surgical treatments pose a substantial challenge. Therefore, government support and financial assistance are crucial aspects to address in managing this condition.

Zenodo (CERN European Organization for Nuclear Research)
Innovative Research (United States) (US)
Openalex Percentile: Top 50%
Cancer, Hypoxia, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Imaging Manifestations of Von Hippel Lindau Disease · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS